DekaBank Deutsche Girozentrale grew its holdings in shares of athenahealth, Inc (NASDAQ:ATHN) by 9.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,237 shares of the health services provider’s stock after buying an additional 687 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in athenahealth were worth $1,262,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Morgan Stanley grew its stake in athenahealth by 0.6% during the second quarter. Morgan Stanley now owns 4,565,845 shares of the health services provider’s stock worth $726,608,000 after buying an additional 25,304 shares during the period. BlackRock Inc. boosted its stake in shares of athenahealth by 3.7% in the second quarter. BlackRock Inc. now owns 1,739,544 shares of the health services provider’s stock valued at $276,833,000 after purchasing an additional 62,665 shares during the period. MERIAN GLOBAL INVESTORS UK Ltd purchased a new position in shares of athenahealth in the third quarter valued at $106,074,000. ARK Investment Management LLC boosted its stake in shares of athenahealth by 12.0% in the second quarter. ARK Investment Management LLC now owns 549,035 shares of the health services provider’s stock valued at $87,373,000 after purchasing an additional 58,631 shares during the period. Finally, Toronto Dominion Bank boosted its stake in shares of athenahealth by 1.0% in the third quarter. Toronto Dominion Bank now owns 446,702 shares of the health services provider’s stock valued at $59,665,000 after purchasing an additional 4,402 shares during the period. Institutional investors own 96.15% of the company’s stock.

ATHN has been the subject of several analyst reports. BidaskClub downgraded shares of athenahealth from a “sell” rating to a “strong sell” rating in a research note on Friday, August 10th. Cantor Fitzgerald restated a “hold” rating and issued a $145.00 target price on shares of athenahealth in a research note on Tuesday, September 18th. SunTrust Banks decreased their target price on shares of athenahealth to $150.00 in a research note on Wednesday, September 19th. MED decreased their target price on shares of athenahealth to $140.00 and set a “hold” rating for the company in a research note on Wednesday, September 19th. Finally, Leerink Swann set a $140.00 target price on shares of athenahealth and gave the company a “buy” rating in a research note on Friday, September 28th. One research analyst has rated the stock with a sell rating, twenty have given a hold rating and three have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $147.71.

In other athenahealth news, insider Daniel P. Haley sold 2,204 shares of the stock in a transaction on Monday, October 1st. The shares were sold at an average price of $127.23, for a total transaction of $280,414.92. Following the transaction, the insider now directly owns 10,555 shares in the company, valued at approximately $1,342,912.65. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders have sold a total of 2,504 shares of company stock worth $317,891 over the last quarter. 2.90% of the stock is currently owned by insiders.

NASDAQ ATHN opened at $132.48 on Thursday. athenahealth, Inc has a 12 month low of $116.77 and a 12 month high of $163.94. The company has a debt-to-equity ratio of 0.22, a quick ratio of 2.74 and a current ratio of 2.74. The firm has a market cap of $5.38 billion, a price-to-earnings ratio of 36.70, a P/E/G ratio of 2.38 and a beta of 0.82.

athenahealth (NASDAQ:ATHN) last posted its quarterly earnings data on Friday, November 9th. The health services provider reported $0.81 EPS for the quarter, beating the Zacks’ consensus estimate of $0.71 by $0.10. athenahealth had a net margin of 9.57% and a return on equity of 15.35%. The firm had revenue of $331.40 million for the quarter, compared to the consensus estimate of $336.98 million. During the same period in the prior year, the firm posted $0.56 EPS. The firm’s revenue was up 8.8% compared to the same quarter last year. On average, research analysts expect that athenahealth, Inc will post 3.15 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “DekaBank Deutsche Girozentrale Grows Holdings in athenahealth, Inc (ATHN)” was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this piece can be read at https://www.watchlistnews.com/dekabank-deutsche-girozentrale-grows-holdings-in-athenahealth-inc-athn/2664019.html.

athenahealth Profile

athenahealth, Inc, together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services.

Featured Story: What do investors mean by earnings per share?

Want to see what other hedge funds are holding ATHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for athenahealth, Inc (NASDAQ:ATHN).

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.